Running exercise reverses depression-induced bone marrow myeloid skewing and neuroinflammation via the lactate-GPR81 axis
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115379 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Bo Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Physical Education, Henan University of Economics and Law, Zhengzhou, Henan Province, China. Electronic address: chenbo@huel.edu.cn. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Depression, Physical Conditioning, Animal, Lactic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Social Science Fund of China, Henan Provincial Science and Technology Research Project.
Themen: Depression
Abstract (Originalsprache)
Exercise has emerged as a powerful non-pharmacological intervention for mental health, yet its precise mechanisms in alleviating depression remain incompletely understood. Here, using a chronic unpredictable stress (CUS) mouse model, we demonstrate that prolonged stress induces hematopoietic stem cell (HSC) activation, leading to myeloid-biased hematopoiesis and an overproduction of Ly6Chigh monocytes, which contribute to systemic and hippocampal inflammation. Notably, treadmill running exercise effectively mitigated depressive and anxiety-like behaviors in CUS mice by suppressing stress-induced HSC activation, restoring hematopoietic balance, and reducing peripheral Ly6Chigh monocyte infiltration into the brain. Mechanistically, we identified systemic lactate elevation as a key mediator of exercise-induced benefits. Circulating lactate levels were markedly increased following exercise in stressed mice, coinciding with upregulation of its receptor GPR81 in bone marrow HSCs. Genetic ablation of GPR81 abrogated the protective effects of exercise, including normalization of HSC proliferation, myeloid skewing, and behavioral recovery, implicating lactate-GPR81 signaling as a critical axis. Furthermore, pharmacological activation of GPR81 in sedentary CUS mice recapitulated the antidepressant and hematopoietic effects of exercise, underscoring its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Physical Education, Henan University of Economics and Law, Zhengzhou, Henan Province, China. Electronic address: chenbo@huel.edu.cn.
- School of Physical Education, Henan University of Economics and Law, Zhengzhou, Henan Province, China.
- Henan Key Laboratory of Infectious Disease Microbiology, Deparament of Prevention and Control of Infectious Disease, Henan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan Province, China.
- School of Sports, Xi'an University, Xi'an, Shaanxi Province, China; SEGi University, Petaling Jaya, Selangor, Malaysia.
- Department of Laboratory Medicine, People's Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan Province, China.
- School of Physical Education, Zhengzhou University, Zhengzhou, Henan Province, China. Electronic address: zhuqiuhan@zzu.edu.cn.
Förderung
- National Social Science Fund of China
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Chen, B., Tian, R., Wu, B., Chen, Z., Liu, D., & Zhu, Q. (2025). Running exercise reverses depression-induced bone marrow myeloid skewing and neuroinflammation via the lactate-GPR81 axis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115379
Vancouver
Chen B, Tian R, Wu B, Chen Z, Liu D, Zhu Q. Running exercise reverses depression-induced bone marrow myeloid skewing and neuroinflammation via the lactate-GPR81 axis. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115379
BibTeX
@article{Chen2025,
author = {Chen, Bo and Tian, Rui and Wu, Bicong and Chen, Zheng and Liu, Di and Zhu, Qiuhan},
title = {Running exercise reverses depression-induced bone marrow myeloid skewing and neuroinflammation via the lactate-GPR81 axis},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115379}
}
EUVIMED